Skip to main content
SYNAIRGEN PLC logo

SYNAIRGEN PLC — Investor Relations & Filings

Ticker · SNG ISIN · GB00B0381Z20 LEI · 213800IMMTOPPDF8HD24 IL Manufacturing
Open in API
Filings indexed 379 across all filing types
Latest filing 2022-01-28 Director's Dealing
Country GB United Kingdom
Listing IL SNG

About SYNAIRGEN PLC

https://www.synairgen.com/

Synairgen PLC is a clinical-stage biotechnology company focused on the discovery and development of treatments for severe respiratory diseases. The company's primary focus is its lead investigative candidate, SNG001, an inhaled formulation of interferon-beta (IFN-β). SNG001 is being developed as a potential host-directed, broad-spectrum antiviral therapy delivered directly to the lungs. This approach aims to treat hospitalized patients with severe viral lung infections caused by a range of pathogens, including influenza, RSV, and coronaviruses.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document is an official notification released via RNS (London Stock Exchange's news service). The content explicitly details a 'Director/PDMR Dealing' transaction, specifically the purchase of ordinary shares by the spouse of a Person Discharging Managerially Responsibilities (PDMR). This type of insider transaction report is specifically categorized as 'Director's Dealing'. The document structure, including the RNS number, date, and detailed transaction tables, confirms this is a regulatory filing concerning insider trading activity.
2022-01-28 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and carries an 'RNS Number'. It details changes in voting rights percentages (crossing thresholds) held by a specific entity (Polar Capital LLP) in the issuer (Synairgen plc), referencing dates and specific regulatory sections (DTR5.1, DTR5.2.1, DTR5.3.1R). This structure perfectly matches the definition of a Major Shareholding Notification, which is categorized as 'MRQ' in the provided schema. Although it is distributed via RNS, the content is highly specific to share ownership changes, making MRQ the most accurate classification over the general RNS fallback.
2022-01-19 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains fields related to voting rights, share ownership thresholds, and notification dates (11/01/2022 and 12/01/2022). This structure is characteristic of regulatory filings concerning changes in significant shareholdings. The RNS Number and the mention of the FCA confirm it is a regulatory disclosure. The definition for Major Shareholding Notification (MRQ) covers 'Notification of changes in significant share ownership levels (crossing thresholds)'. Although it is distributed via RNS, the core content is a specific major holding notification, making MRQ the most precise classification over the general RNS fallback.
2022-01-12 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified as a 'TR-1: Standard form for notification of major holdings' filed with the RNS (Regulatory News Service) of the London Stock Exchange. This form is used to report changes in significant share ownership (crossing notification thresholds). This directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content is a major holding notification, making MRQ the most precise classification over the general RNS fallback.
2022-01-07 English
Synairgen announces partnership with Ashfield
Regulatory Filings Classification · 98% confidence The document is identified by the header 'RNS Number : 6659X' and is explicitly labeled as a 'Press Release'. It announces a 'global strategic partnership' between Synairgen plc and Ashfield Engage regarding the commercialization of SNG001. The footer explicitly states, 'Reach is a non-regulatory news service... Reach announcements are identified with an orange label...'. Since this is a press release announcing a business development that does not fit into specific financial reporting categories (like 10-K, ER, or DIV), and it is explicitly identified as a non-regulatory announcement distributed via the RNS system (Reach service), the most appropriate classification is the general regulatory/announcement fallback category, RNS.
2022-01-06 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with "RNS Number : 6806W" and contains the standard header/footer information associated with RNS (Regulatory News Service) announcements from the London Stock Exchange. The content details a "TR-1: Standard form for notification of major holdings" concerning an acquisition/disposal of voting rights by Polar Capital LLP, which is a mandatory disclosure for significant changes in share ownership. This type of filing, reporting changes in major shareholdings (crossing thresholds), maps directly to the Major Shareholding Notification category (MRQ). Although RNS is present, MRQ is more specific than the general RNS fallback.
2021-12-23 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.